Latest filing published 22 Jun 2026 for Enliven Therapeutics, Inc., €33.5M.
Insider track record
OrbiMed Private Investments VII, LP: trading record in brief
This profile gathers the share dealings of OrbiMed Private Investments VII, LP in Enliven Therapeutics, Inc. The record holds 2 filings, for trades running from 15 June 2026 to 22 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 22 June 2026 with a transaction (€33.5M) in Enliven Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to OrbiMed Private Investments VII, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 833,800 shares@ US$45.961.05% mcap77.1% of flowCommon StockSEC144:0000947871-26-000649
- 272,322 shares@ US$42.360.31% mcap22.9% of flowCommon StockSEC144:0000947871-26-000628
2 of 2 declarations
